These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30208338)

  • 1. Serotonin contribution to cardiac valve degeneration: new insights for novel therapies?
    Ayme-Dietrich E; Lawson R; Da-Silva S; Mazzucotelli JP; Monassier L
    Pharmacol Res; 2019 Feb; 140():33-42. PubMed ID: 30208338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.
    Oyama MA; Elliott C; Loughran KA; Kossar AP; Castillero E; Levy RJ; Ferrari G
    Cardiovasc Pathol; 2020; 46():107196. PubMed ID: 32006823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin and catecholamines in the development and progression of heart valve diseases.
    Goldberg E; Grau JB; Fortier JH; Salvati E; Levy RJ; Ferrari G
    Cardiovasc Res; 2017 Jul; 113(8):849-857. PubMed ID: 28863437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin receptor 2B signaling with interstitial cell activation and leaflet remodeling in degenerative mitral regurgitation.
    Driesbaugh KH; Branchetti E; Grau JB; Keeney SJ; Glass K; Oyama MA; Rioux N; Ayoub S; Sacks MS; Quackenbush J; Levy RJ; Ferrari G
    J Mol Cell Cardiol; 2018 Feb; 115():94-103. PubMed ID: 29291394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of 5-HT
    Ayme-Dietrich E; Lawson R; Côté F; de Tapia C; Da Silva S; Ebel C; Hechler B; Gachet C; Guyonnet J; Rouillard H; Stoltz J; Quentin E; Banas S; Daubeuf F; Frossard N; Gasser B; Mazzucotelli JP; Hermine O; Maroteaux L; Monassier L
    Br J Pharmacol; 2017 Nov; 174(22):4123-4139. PubMed ID: 28806488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of serotoninergic pathways in drug-induced valvular heart disease and diagnostic features by echocardiography.
    Smith SA; Waggoner AD; de las Fuentes L; Davila-Roman VG
    J Am Soc Echocardiogr; 2009 Aug; 22(8):883-9. PubMed ID: 19553085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling pathways in mitral valve degeneration.
    Orton EC; Lacerda CM; MacLea HB
    J Vet Cardiol; 2012 Mar; 14(1):7-17. PubMed ID: 22364692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of Contemporary Valve Surgery in Patients with Carcinoid Heart Disease.
    Kuntze T; Owais T; Secknus MA; Kaemmerer D; Baum R; Girdauskas E
    J Heart Valve Dis; 2016 May; 25(3):356-363. PubMed ID: 27989047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering.
    Schoen FJ
    Circulation; 2008 Oct; 118(18):1864-80. PubMed ID: 18955677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cellular changes in Cavalier King Charles spaniel and mixed breed dogs with myxomatous mitral valve disease.
    Lu CC; Liu MM; Culshaw G; French A; Corcoran B
    J Vet Cardiol; 2016 Jun; 18(2):100-9. PubMed ID: 26860643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanobiology of drug-induced cardiac valve disease.
    Lam NT; Balachandran K
    J Long Term Eff Med Implants; 2015; 25(1-2):27-40. PubMed ID: 25955005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the spontaneous degenerative mitral valve disease in FVB mice.
    Ayme-Dietrich E; Da Silva S; Bouabout GA; Arnoux A; Guyonnet J; Becker G; Monassier L
    PLoS One; 2021; 16(9):e0257022. PubMed ID: 34473777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct signaling pathways activated by "extracellular" and "intracellular" serotonin in heart valve development and disease.
    Pavone LM; Norris RA
    Cell Biochem Biophys; 2013; 67(3):819-28. PubMed ID: 23605455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of function and disease of natural and replacement heart valves.
    Schoen FJ
    Annu Rev Pathol; 2012; 7():161-83. PubMed ID: 21942526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The best of valvular heart disease in 2006].
    de Gevigney G;
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():19-28. PubMed ID: 17405561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-related cardiac valve disease.
    Prescrire Int; 2013 Dec; 22(144):292-5. PubMed ID: 24600729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine serotonin and transforming growth factor beta 1 signaling mediates spontaneous myxomatous mitral valve disease.
    Disatian S; Orton EC
    J Heart Valve Dis; 2009 Jan; 18(1):44-51. PubMed ID: 19301552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoid heart disease.
    Gustafsson BI; Hauso O; Drozdov I; Kidd M; Modlin IM
    Int J Cardiol; 2008 Oct; 129(3):318-24. PubMed ID: 18571250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin receptors and heart valve disease--it was meant 2B.
    Hutcheson JD; Setola V; Roth BL; Merryman WD
    Pharmacol Ther; 2011 Nov; 132(2):146-57. PubMed ID: 21440001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine.
    Fitzgerald LW; Burn TC; Brown BS; Patterson JP; Corjay MH; Valentine PA; Sun JH; Link JR; Abbaszade I; Hollis JM; Largent BL; Hartig PR; Hollis GF; Meunier PC; Robichaud AJ; Robertson DW
    Mol Pharmacol; 2000 Jan; 57(1):75-81. PubMed ID: 10617681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.